Table of Contents
ISRN Gastroenterology
Volume 2012, Article ID 935410, 9 pages
http://dx.doi.org/10.5402/2012/935410
Review Article

Eradication Treatment of Helicobacter pylori Infection: Its Importance and Possible Relationship in Preventing the Development of Gastric Cancer

1Department of Clinical Medicine, Faculty of Medical Sciences, State University of Campinas (UNICAMP), 13.081-970 Campinas, SP, Brazil
2Center of Diagnosis of Digestive Diseases, Faculty of Medical Sciences, State University of Campinas (UNICAMP), 13.081-970 Campinas, SP, Brazil

Received 11 February 2012; Accepted 17 March 2012

Academic Editors: S. Bereswill, L. David, M. Kato, and J. M. Pajares

Copyright © 2012 Bruna Maria Roesler et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. J. Marshall and J. R. Warren, “Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration,” Lancet, vol. 1, no. 8390, pp. 1311–1314, 1984. View at Google Scholar · View at Scopus
  2. T. Yamada, J. G. Searle, D. Ahnen et al., “Helicobacter pylori in peptic ulcer disease,” The Journal of the American Medical Association, vol. 272, no. 1, pp. 65–69, 1994. View at Google Scholar
  3. N. Uemura, S. Okamoto, S. Yamamoto et al., “Helicobacter pylori infection and the development of gastric cancer,” New England Journal of Medicine, vol. 345, no. 11, pp. 784–789, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. A. C. Wotherspoon, C. Ortiz-Hidalgo, M. R. Falzon, and P. G. Isaacson, “Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma,” Lancet, vol. 338, no. 8776, pp. 1175–1176, 1991. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Sugiyama and M. Asaka, “Helicobacter pylori infection and gastric cancer,” Medical Electron Microscopy, vol. 37, no. 3, pp. 149–157, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Herrera and J. Parsonnet, “Helicobacter pylori and gastric adenocarcinoma,” Clinical Microbiology and Infection, vol. 15, no. 11, pp. 971–976, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Parsonnet, G. D. Friedman, N. Orentreich, and H. Vogelman, “Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection,” Gut, vol. 40, no. 3, pp. 297–301, 1997. View at Google Scholar · View at Scopus
  8. M. Asaka, T. Kimura, M. Kato et al., “Possible role of Helicobacter pylori infection in early gastric cancer development,” Cancer, vol. 73, no. 11, pp. 2691–2694, 1994. View at Google Scholar
  9. E. J. Kuipers, G. I. Perez-Perez, S. G. M. Meuwissen, and M. J. Blaser, “Helicobacter pylori and atrophic gastritis: importance of the cagA status,” Journal of the National Cancer Institute, vol. 87, no. 23, pp. 1777–1780, 1995. View at Google Scholar · View at Scopus
  10. International Agency for Research on Cancer, Schistosomes, Liver Flukes and Helicobacter pylori, vol. 61 of IARC Monographs on the Evaluation of Carcinogenic Risks to Human, IARC, Lyons, France, 1994.
  11. S. Kabir, C. Grant, and A. S. Daar, “Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma,” Cancer Letters, vol. 95, no. 1-2, pp. 207–212, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. E. M. El-Omar, M. Carrington, W. H. Chow et al., “Interleukin-1 polymorphisms associated with increased risk of gastric cancer,” Nature, vol. 404, no. 6776, pp. 398–402, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Correa, M. B. Piazuelo, and M. C. Camargo, “The future of gastric cancer prevention,” Gastric Cancer, vol. 7, no. 1, pp. 9–16, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Ando, Y. Goto, K. Ishiguro et al., “The interaction of host genetic factors and Helicobacter pylori infection,” Inflammopharmacology, vol. 15, no. 1, pp. 10–14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Kabir, “Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events,” Helicobacter, vol. 14, no. 3, pp. 159–171, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Uemura, T. Mukai, S. Okamoto et al., “Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 6, no. 8, pp. 639–642, 1997. View at Google Scholar · View at Scopus
  17. P. Malfertheiner, F. Megraud, C. O'Morain et al., “Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report,” Gut, vol. 56, no. 6, pp. 772–781, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. W. D. Chey and B. C. Y. Wong, “American College of Gastroenterology guideline on the management of Helicobacter pylori infection,” American Journal of Gastroenterology, vol. 102, no. 8, pp. 1808–1825, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. K. M. Fock, P. Katelaris, K. Sugano et al., “Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection,” Journal of Gastroenterology and Hepatology, vol. 24, no. 10, pp. 1587–1600, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Moayyedi, J. Deeks, N. J. Talley, B. Delaney, and D. Forman, “An update of the cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews,” American Journal of Gastroenterology, vol. 98, no. 12, pp. 2621–2626, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Moayyedi, S. Soo, J. Deeks et al., “Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia,” BMJ, vol. 321, no. 7262, pp. 659–664, 2000. View at Google Scholar · View at Scopus
  22. L. Laine and J. Sugg, “Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies,” American Journal of Gastroenterology, vol. 97, no. 12, pp. 2992–2997, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Caselli, A. Zullo, G. Maconi et al., “"Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy,” Digestive and Liver Disease, vol. 39, no. 8, pp. 782–789, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. S. J. O. Veldhuyzen van Zanten, M. Bradette, N. Chiba et al., “Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool,” Canadian Journal of Gastroenterology, vol. 19, no. 5, pp. 285–303, 2005. View at Google Scholar · View at Scopus
  25. F. Mégraud and H. Lamouliatte, “Review article: the treatment of refractory Helicobacter pylori infection,” Alimentary Pharmacology and Therapeutics, vol. 17, no. 11, pp. 1333–1343, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. B. J. McMahon, T. W. Hennessy, J. M. Bensler et al., “The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections,” Annals of Internal Medicine, vol. 139, no. 6, pp. 463–469, 2003. View at Google Scholar · View at Scopus
  27. A. Zullo, D. Vaira, N. Vakil et al., “High eradication rates of Helicobacter pylori with a new sequential treatment,” Alimentary Pharmacology and Therapeutics, vol. 17, no. 5, pp. 719–726, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. V. De Francesco, A. Zullo, M. Margiotta et al., “Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure,” Alimentary Pharmacology and Therapeutics, vol. 19, no. 4, pp. 407–414, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. S.-K. Chuah, F.-W. Tsay, P.-I. Hsu et al., “A new look at anti-Helicobacter pylori therapy,” World Journal of Gastroenterology, vol. 17, no. 35, pp. 3971–3975, 2011. View at Google Scholar
  30. S. Pontone, M. Standoli, R. Angelini, and P. Pontone, “Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice,” Digestive and Liver Disease, vol. 42, no. 8, pp. 541–543, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. J. P. Gisbert, X. Calvet, L. Bujanda, S. Marcos, J. L. Gisbert, and J. M. Pajares, “'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures,” Helicobacter, vol. 8, no. 2, pp. 90–94, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. V. De Francesco, E. Ierardi, C. Hassan, and A. Zullo, “Is furazolidone therapy for Helicobacter pylori effective and safe?” Digestive Diseases and Sciences, vol. 54, no. 10, p. 2298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Zullo, E. Ierardi, C. Hassan et al., “Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis,” Saudi Journal of Gastroenterology, vol. 18, no. 1, pp. 11–17, 2012. View at Google Scholar
  34. P. Malfertheiner, J. Bornschein, and M. Selgrad, “Role of Helicobacter pylori infection in gastric cancer pathogenesis: a chance for prevention,” Journal of Digestive Diseases, vol. 11, no. 1, pp. 2–11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Nardone, A. Rocco, and P. Malfertheiner, “Review article: Helicobacter pylori and molecular events in precancerous gastric lesions,” Alimentary Pharmacology and Therapeutics, vol. 20, no. 3, pp. 261–270, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Hohenberger and S. Gretschel, “Gastric cancer,” Lancet, vol. 362, no. 9380, pp. 305–315, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Lauren, “The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma,” Acta Pathologica et Microbiologica Scandinavica, vol. 64, pp. 31–49, 1965. View at Google Scholar · View at Scopus
  38. M. Barber, R. C. Fitzgerald, and C. Caldas, “Familial gastric cancer—aetiology and pathogenesis,” Best Practice and Research: Clinical Gastroenterology, vol. 20, no. 4, pp. 721–734, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Bornschein and P. Malfertheiner, “Gastric carcinogenesis,” Langenbeck's Archives of Surgery, vol. 396, no. 6, pp. 729–742, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Correa, W. Haenszel, and C. Cuello, “A model for gastric cancer epidemiology,” Lancet, vol. 2, no. 7924, pp. 58–59, 1975. View at Google Scholar · View at Scopus
  41. P. Correa and J. Houghton, “Carcinogenesis of Helicobacter pylori,” Gastroenterology, vol. 133, no. 2, pp. 659–672, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Bornschein, M. Selgrad, M. Warnecke, D. Kuester, T. Wex, and P. Malfertheiner, “H. pylori infection is a key risk factor for proximal gastric cancer,” Digestive Diseases and Sciences, vol. 55, no. 11, pp. 3124–3131, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Hansen, S. E. Vollset, M. H. Derakhshan et al., “Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status,” Gut, vol. 56, no. 7, pp. 918–925, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. M. J. Bowles and I. S. Benjamin, “ABC of the upper gasrointestinal tract: cancer of the stomach and pancreas,” BMJ, vol. 323, no. 7326, pp. 1413–1416, 2001. View at Google Scholar · View at Scopus
  45. S. M. Everett and A. T. R. Axon, “Early gastric cancer: disease or pseudo-disease?” Lancet, vol. 351, no. 9112, pp. 1350–1352, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. Japanese Research Society for Gastric Cancer, “The general rules for the gastric cancer,” Japanese Journal of Surgery, vol. 3, pp. 61–71, 1973. View at Google Scholar
  47. N. Akopyanz, N. O. Bukanov, T. U. Westblom, S. Kresovich, and D. E. Berg, “DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting,” Nucleic Acids Research, vol. 20, no. 19, pp. 5137–5142, 1992. View at Google Scholar · View at Scopus
  48. F. C. Han, H. C. Ng, and B. Ho, “Stability of randomly amplified polymorphic DNA fingerprinting in genotyping clinical isolates of Helicobacter pylori,” World Journal of Gastroenterology, vol. 9, no. 9, pp. 2021–2024, 2003. View at Google Scholar · View at Scopus
  49. B. M. Röesler, T. B. De Oliveira, S. H. A. Bonon, L. T. Monici, J. M. R. Zeitune, and S. C. B. Costa, “Restriction fragment length polymorphism of urease C and urease B genes of Helicobacter pylori strains isolated from brazilian patients with peptic ulcer and chronic gastritis,” Digestive Diseases and Sciences, vol. 54, no. 7, pp. 1487–1493, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Censini, C. Lange, Z. Xiang et al., “cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 25, pp. 14648–14653, 1996. View at Google Scholar · View at Scopus
  51. A. T. Franco, E. Johnston, U. Krishna et al., “Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors,” Cancer Research, vol. 68, no. 2, pp. 379–387, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. M. J. Blaser, G. I. Perez-Perez, H. Kleanthous et al., “Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach,” Cancer Research, vol. 55, no. 10, pp. 2111–2115, 1995. View at Google Scholar · View at Scopus
  53. S. K. Wang, H. F. Zhu, B. S. He et al., “CagA+ H pylori infection is associated with polarization of T helper cell immune responses in gastric carcinogenesis,” World Journal of Gastroenterology, vol. 13, no. 21, pp. 2923–2931, 2007. View at Google Scholar · View at Scopus
  54. S. Odenbreit, J. Püls, B. Sedlmaier, E. Gerland, W. Fischer, and R. Haas, “Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion,” Science, vol. 287, no. 5457, pp. 1497–1500, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Higashi, R. Tsutsumi, S. Muto et al., “SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein,” Science, vol. 295, no. 5555, pp. 683–686, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. A. T. Franco, D. A. Israel, M. K. Washington et al., “Activation of β-catenin by carcinogenic Helicobacter pylori,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 30, pp. 10646–10651, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. N. Murata-Kamiya, Y. Kurashima, Y. Teishikata et al., “Helicobacter pylori CagA interacts with E-cadherin and deregulates the β-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells,” Oncogene, vol. 26, no. 32, pp. 4617–4626, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. M. R. Amieva, R. Vogetmann, A. Covacci, L. S. Tompkins, W. J. Nelson, and S. Falkow, “Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA,” Science, vol. 300, no. 5624, pp. 1430–1434, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Suzuki, H. Mimuro, T. Suzuki, M. Park, T. Yamamoto, and C. Sasakawa, “Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion,” Journal of Experimental Medicine, vol. 202, no. 9, pp. 1235–1247, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Bagnoli, L. Buti, L. Tompkins, A. Covacci, and M. R. Amieva, “Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 45, pp. 16339–16344, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. A. R. Pacheco, J. L. Proença-Módena, A. I. L. Sales et al., “Involvement of the Helicobacter pylori plasticity region and cag pathogenicity island genes in the development of gastroduodenal diseases,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 27, no. 11, pp. 1053–1059, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. B. M. Roesler, S. C. B. Costa, and J. M. R. Zeitune , “Virulence factors of Helicobacter pylori and their relationship with the development of early and advanced distal intestinal type gastric adenocarcinoma,” in Gastritis and Gastric Cancer—New Insights in Gastroprotection, Diagnosis and Treatments, P. Tonino, Ed., pp. 259–280, InTech, Croatia, 2011. View at Google Scholar
  63. J. C. Atherton, “The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases,” Annual Review of Pathology, vol. 1, pp. 63–96, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. T. L. Cover and S. R. Blanke, “Helicobacter pylori VacA, a paradigm for toxin multifunctionality,” Nature Reviews Microbiology, vol. 3, no. 4, pp. 320–332, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. J. G. Kusters, A. H. M. Van Vliet, and E. J. Kuipers, “Pathogenesis of Helicobacter pylori infection,” Clinical Microbiology Reviews, vol. 19, no. 3, pp. 449–490, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. B. Gebert, W. Fischer, E. Weiss, R. Hoffmann, and R. Haas, “Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation,” Science, vol. 301, no. 5636, pp. 1099–1102, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. J. C. Atherton, P. Cao, R. M. Peek, M. K. R. Tummuru, M. J. Blaser, and T. L. Cover, “Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration,” Journal of Biological Chemistry, vol. 270, no. 30, pp. 17771–17777, 1995. View at Publisher · View at Google Scholar · View at Scopus
  68. D. P. Letley, A. Lastovica, J. A. Louw, C. J. Hawkey, and J. C. Atherton, “Allelic diversity of the Helicobacter priori vacuolating cytotoxin gene in South Africa: rarity of the vacA s1a genotype and natural occurrence of an s2/m1 allele,” Journal of Clinical Microbiology, vol. 37, no. 4, pp. 1203–1205, 1999. View at Google Scholar · View at Scopus
  69. J. L. Rhead, D. P. Letley, M. Mohammadi et al., “A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is Associated with gastric cancer,” Gastroenterology, vol. 133, no. 3, pp. 926–936, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Sugimoto and Y. Yamaoka, “The association of vacA genotype and Helicobacter pylori-related disease in Latin American and African populations,” Clinical Microbiology and Infection, vol. 15, no. 9, pp. 835–842, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. T. Kudo, Z. Z. Nurgalieva, M. E. Conner et al., “Correlation between Helicobacter pylori OipA Protein Expression and oipA Gene Switch Status,” Journal of Clinical Microbiology, vol. 42, no. 5, pp. 2279–2281, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Dossumbekova, C. Prinz, J. Mages et al., “Helicobacter pylori HopH (OipA) and bacterial pathogenicity: genetic and functional genomic analysis of hopH gene polymorphisms,” Journal of Infectious Diseases, vol. 194, no. 10, pp. 1346–1355, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Dossumbekova, C. Prinz, M. Gerhard et al., “Helicobacter pylori outer membrane proteins and gastric inflammation,” Gut, vol. 55, no. 9, pp. 1360–1361, 2006. View at Google Scholar · View at Scopus
  74. Y. Yamaoka, D. H. Kwon, and D. Y. Graham, “A Mr 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 13, pp. 7533–7538, 2000. View at Google Scholar · View at Scopus
  75. G. Nardone and A. Morgner, “Helicobacter pylori and gastric malignancies,” Helicobacter, vol. 8, no. 1, pp. 44–52, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. J. C. Machado, C. Figueiredo, P. Canedo et al., “A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma,” Gastroenterology, vol. 125, no. 2, pp. 364–371, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. L. Hou, E. M. El-Omar, J. Chen et al., “Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer,” Carcinogenesis, vol. 28, no. 1, pp. 118–123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. T. Wex, M. P. A. Ebert, S. Kropf et al., “Gene polymorphisms of the NOD-2/CARD-15 gene and the risk of gastric cancer in Germany,” Anticancer Research, vol. 28, no. 2 A, pp. 757–762, 2008. View at Google Scholar · View at Scopus
  79. D. Santini, S. Angeletti, A. Ruzzo et al., “Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes,” Clinical and Experimental Immunology, vol. 154, no. 3, pp. 360–364, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. R. Pandey, V. Misra, S. P. Misra, M. Dwivedi, A. Kumar, and B. K. Tiwari, “Helicobacter pylori and gastric cancer,” Asian Pacific Journal of Cancer Prevention, vol. 11, no. 3, pp. 583–588, 2010. View at Google Scholar · View at Scopus
  81. L. T. Ngoan, T. Mizoue, Y. Fujino, N. Tokui, and T. Yoshimura, “Dietary factors and stomach cancer mortality,” British Journal of Cancer, vol. 87, no. 1, pp. 37–42, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Chao, M. J. Thun, S. Jane Henley, E. J. Jacobs, M. L. McCullough, and E. E. Calle, “Cigarette smoking, use of other tobacco products and stomach cancer mortality in US adults: the cancer prevention study II,” International Journal of Cancer, vol. 101, no. 4, pp. 380–389, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. Y. Nishino, M. Inoue, I. Tsuji et al., “Tobacco smoking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population,” Japanese Journal of Clinical Oncology, vol. 36, no. 12, pp. 800–807, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. R. Ladeiras-Lopes, A. K. Pereira, A. Nogueira et al., “Smoking and gastric cancer: systematic review and meta-analysis of cohort studies,” Cancer Causes and Control, vol. 19, no. 7, pp. 689–701, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. J. Steevens, L. J. Schouten, R. A. Goldbohm, and P. A. Van Den Brandt, “Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study,” Gut, vol. 59, no. 1, pp. 39–48, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. J. J. Y. Sung, S. R. Lin, J. Y. L. Ching et al., “Atrophy and intestinal metaplasia one year after-cure of H. pylori Infection: a prospective, randomized study,” Gastroenterology, vol. 119, no. 1, pp. 7–14, 2000. View at Google Scholar · View at Scopus
  87. W. K. Leung and J. J. Y. Sung, “Review article: intestinal metaplasia and gastric carcinogenesis,” Alimentary Pharmacology and Therapeutics, vol. 16, no. 7, pp. 1209–1216, 2002. View at Publisher · View at Google Scholar · View at Scopus
  88. P. Correa, E. T. H. Fontham, J. C. Bravo et al., “Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy,” Journal of the National Cancer Institute, vol. 92, no. 23, pp. 1881–1888, 2000. View at Google Scholar · View at Scopus
  89. R. Mera, E. T. H. Fontham, L. E. Bravo et al., “Long term follow up of patients treated for Helicobacter pylori infection,” Gut, vol. 54, no. 11, pp. 1536–1540, 2005. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Take, M. Mizuno, K. Ishiki et al., “The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease,” American Journal of Gastroenterology, vol. 100, no. 5, pp. 1037–1042, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. T. Kamada, J. Hata, K. Sugiu et al., “Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan,” Alimentary Pharmacology and Therapeutics, vol. 21, no. 9, pp. 1121–1126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. R. Takenaka, H. Okada, J. Kato et al., “Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type,” Alimentary Pharmacology and Therapeutics, vol. 25, no. 7, pp. 805–812, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. K. Ogura, Y. Hirata, A. Yanai et al., “The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer,” Journal of Clinical Gastroenterology, vol. 42, no. 3, pp. 279–283, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. B. C. Y. Wong, S. K. Lam, W. M. Wong et al., “Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of china: a randomized controlled trial,” Journal of the American Medical Association, vol. 291, no. 2, pp. 187–194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  95. K. Mabe, M. Takahashi, H. Oizumi et al., “Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?” World Journal of Gastroenterology, vol. 15, no. 34, pp. 4290–4297, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. L. Fuccio, R. M. Zagari, M. E. Minardi, and F. Bazzoli, “Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer,” Alimentary Pharmacology and Therapeutics, vol. 25, no. 2, pp. 133–141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. T. K. Cheung and B. C. Y. Wong, “Treatment of Helicobacter pylori and prevention of gastric cancer,” Journal of Digestive Diseases, vol. 9, no. 1, pp. 8–13, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. V. Herrera and J. Parsonnet, “Helicobacter pylori and gastric adenocarcinoma,” Clinical Microbiology and Infection, vol. 15, no. 11, pp. 971–976, 2009. View at Publisher · View at Google Scholar · View at Scopus
  99. H. Ono, H. Kondo, T. Gotoda et al., “Endoscopic mucosal resection for treatment of early gastric cancer,” Gut, vol. 48, no. 2, pp. 225–229, 2001. View at Publisher · View at Google Scholar · View at Scopus
  100. K. Fukase, M. Kato, S. Kikuchi et al., “Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label randomized controlled trial,” Lancet, vol. 1372, no. 9636, pp. 392–397, 2008. View at Google Scholar
  101. Y. Maehata, S. Nakamura, K. Fujisawa et al., “Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer,” Gastrointestinal Endoscopy, vol. 75, no. 1, pp. 39–46, 2012. View at Google Scholar
  102. T. Matsuo, M. Ito, M. Tatsugami et al., “Gastric cancer development after Helicobacter pylori eradication therapy: a new form of gastric neoplasia,” Digestion, vol. 85, no. 1, pp. 61–67, 2012. View at Google Scholar
  103. T. Oda, K. Murakami, A. Nishizono, M. Kodama, M. Nasu, and T. Fujioka, “Long-term Helicobacter pylori infection in Japanese monkeys induces atrophic gastritis and accumulation of mutations in the p53 tumor suppressor gene,” Helicobacter, vol. 7, no. 3, pp. 143–151, 2002. View at Publisher · View at Google Scholar · View at Scopus